Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,778.40
(
-0.07%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
110.40
(
3.58%
)
Bitcoin
70,439.30
(
-1.13%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: investorgold2002 post# 120235

Wednesday, 05/18/2011 8:56:29 AM

Wednesday, May 18, 2011 8:56:29 AM

Post# of 257257

I believe they were 45% of the overall market when they were 70% of retail?

Generic Lovenox had a 44% share of dollar sales in 1Q11 (#msg-62519040).

Now you are saying they are 85% of retail in April?

That’s what IMS is reporting (#msg-63248831).

Wasn't retail 30% and GPO 70% of the total market?

Retail is approximately 30% of the US Lovenox market by prescription volume and approximately 40% by dollar sales (#msg-54355727).

“The notion that there’s a Chinese Wall between sell-side analysts
and investment bankers may be the second-biggest piece of BS
ever promulgated in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now